AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yi, C. A
Right arrow Articles by Chung, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yi, C. A
Right arrow Articles by Chung, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.2082
AJR 2007; 189:386-392
© American Roentgen Ray Society


Original Research

3-T MRI: Usefulness for Evaluating Primary Lung Cancer and Small Nodules in Lobes Not Containing Primary Tumors

Chin A Yi1, Tae Yeon Jeon1, Kyung Soo Lee1, Jung Hee Lee1, Joon Beom Seo2, Yoon Kyung Kim1 and Myung Jin Chung1

1 Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Korea.
2 Department of Radiology and Medical Imaging Laboratory, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Received October 24, 2006; accepted after revision February 28, 2007.

 
Address correspondence to K. S Lee (kyungs.lee{at}samsung.com).

Supported by Samsung Clinical Research Development Project Grants (CRS105-22-1 and CRS 106-10-1).


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of this study was to evaluate the diagnostic performance of 3-T MRI in the detection and characterization of primary non-small cell lung cancer and of small nodules in lobes not containing primary tumors.

MATERIALS AND METHODS. From July 2005 to May 2006, 127 patients (99 men, 28 women; mean age, 63 years) with histopathologically proven non-small cell lung cancer underwent both CT and MRI of the chest. Transverse MR images were obtained with T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood turbo spin-echo sequences on a 3-T MRI system. Two chest radiologists assessed CT images and then MR images. The morphologic features of lung cancer and the detectability of small nodules in lobes not containing primary tumors on MR images were compared with the findings on CT images, which were the reference standard.

RESULTS. The morphologic characteristics of primary cancer found on both T1- and T2-weighted images corresponded to those on CT images. The overall rates of detection of nodules in lobes not containing primary tumors were 57% (184 of 323 nodules) and 56% (180 of 323 nodules) on T1- and T2-weighted images, respectively (p = 0.64). In terms of detection of non-calcified nodules 5-10 mm in diameter, both T1- and T2-weighted images had a detection rate of 92% (48 of 52 nodules) (p =1.00).

CONCLUSION. Both T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood turbo spin-echo 3-T MR images depict clinically significant small (5-10 mm in diameter) noncalcified pulmonary nodules nearly as well as do CT scans.

Keywords: high field strength • lung • lung neoplasms • lung nodule • MRI


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Although improved soft-tissue contrast enhancement, intrinsic flow sensitivity, and the absence of ionizing radiation are advantages of MRI over CT, CT of the thorax is considered the standard technique for assessing the intrathoracic spread of non-small cell lung cancer (NSCLC) [1, 2]. Because of the following shortcomings, MRI has not been emphasized in thoracic imaging: low signal-to-noise ratio due to low proton density in inflated lungs, susceptibility artifacts caused by many air-tissue interfaces, and motion artifact vulnerability related to a relatively long acquisition time and intrinsic cardiac pulsation and respiration. Some reports [3, 4], however, have described the potential role of MRI in accurate staging of NSCLC, in detection of mediastinal invasion by tumor, and in prediction of hilar and mediastinal nodal metastasis. Dynamic MRI shows marked kinetic—that is, vascularity and perfusion—and morphologic differences between malignant and benign solitary pulmonary nodules [5, 6]. The rate of detection of variously sized pulmonary nodules with MRI has been evaluated with a HASTE sequence on a 1.5-T MRI system [7] in which pulmonary lesions larger than 5 mm in diameter were readily detected.

Signal-to-noise ratio is directly related to static magnetic field strength. Because of improved signal-to-noise ratios, MR units with field strength greater than 1.5 T have been found to have upgraded capabilities in terms of temporal and spatial resolution [8-10]. High-field-strength magnets, however, are prone to problems, such as increased susceptibility effects due to magnetic field inhomogeneity, especially when large fields of view are used [3].

The turbo spin-echo (TSE) sequence has been proposed to reduce susceptibility artifacts and to increase signal-to-noise ratio. This sequence is based on rapid repetitive rephrasing with a train of multiple 180° refocusing pulses, particularly with short echo spacing. Therefore, TSE sequences appear to be suitable for lung MRI. A more refined T2-weighted TSE sequence adopts breath-hold ECG-gated and black blood technique to eliminate flow and motion artifacts in the lung [11]. In addition, STIR sequences for fat suppression can enhance the conspicuity of focal lung lesions [11, 12]. The HASTE sequence for breath-hold cardiac-gated T2-weighted imaging is another practical thoracic imaging sequence for lung parenchyma [13]. HASTE images, however, are usually blurred because of T2 decay in later echoes during data acquisition. To the best of our knowledge, these newly developed and refined pulse sequences, which are based on TSE applications, have not been used for thoracic imaging under high-field-strength conditions. The purpose of our study was to evaluate the diagnostic performance of 3-T MRI for the detection and characterization of primary NSCLC and of small nodules in lobes not containing primary tumors.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Patients
From July 2005 to May 2006, a total of 135 consecutively registered patients with pathologically proven NSCLC and no suspected metastatic lesions on the basis of findings on conventional chest CT were scheduled for thoracic 3-T MRI (Achieva, Philips Medical Systems) for evaluation of the diagnostic efficacy of the technique in determination of T and N stages. Eight of the 135 patients were excluded for the following reasons: contraindication to MRI because of the presence of a pacemaker or other metallic implant in six cases and premature cessation of MRI because of claustrophobia in two cases. Therefore, this study included 127 patients (99 men and 28 women; age range, 34-82 years; mean, 63 years). Thoracic MRI was performed within 7 days (mean, 4.8 days) of CT.

In all 127 cases, the histopathologic cell type of the primary tumor was determined with percutaneous needle aspiration biopsy (n =15) or surgery (n = 112). The pathologic subtypes of lung cancer were as follows: adenocarcinoma in 60 (47%), squamous cell carcinoma in 41 (32%), NSCLC of unspecified subtype in 17 (13%), large cell neuroendocrine carcinoma in four (3%), sarcomatoid carcinoma (spindle cell carcinoma) in three (3%), and pleomorphic carcinoma in two (2%) of the cases.

CT Imaging
All chest CT scans were obtained with 4-MDCT (LightSpeed QX/i, GE Healthcare) or 16-MDCT (LightSpeed Ultra or Ultra16, GE Healthcare) scanners. After IV administration of contrast medium (2 mL/s; total, 80 mL of iomeprol, Iomeron 300, Bracco) with a power injector (MCT Plus, Medrad), CT scans (125 mA, 120 kVp, beam width of 10-20 mm, beam pitch of 1.375-1.5) for tumor staging were obtained from the lung apices to the level of the middle portion of both kidneys. Image data were reconstructed with a bone algorithm and 5.0-mm section thickness. All image data were directly interfaced with a PACS workstation (Path-speed, GE Healthcare), which displayed all image data on monitors (four monitors, 1,536 x 2,048 matrix size, 8-bit viewable gray scale, 60-foot-lambert luminescence). Both mediastinal (width, 400 H; level, 20 H) and lung (width, 1,500 H; level, -700 H) windows were viewed on these monitors.

MRI
All MRI studies were performed with a 3-T unit (Achieva, Philips Medical Systems) equipped with a gradient system capable of a maximum gradient amplitude of 80 mT/m, rise time of 0.2 millisecond, and slew rate of 200 T/m/s. A sensitivity-encoding cardiac coil with a six-coil element was used to obtain axial images of the thorax.

A breath-hold T2-weighted triple inversion black blood TSE sequence was used with cardiac gating and the following parameters: TR/TEeff, 1,200-1,800/60 (2 R-R intervals); echo-train length, 21; field of view, 400 mm; acquisition matrix size, 256 reconstructed to 512; slice thickness, 5 mm with 1-mm interslice gap. A double-inversion blood-nulling preparation pulse was applied at the R-wave trigger to suppress blood signals with an inversion delay time of 697.6 milliseconds and was followed by a third inversion pulse to generate spectral presaturation attenuated by inversion recovery contrast enhancement for fat suppression and a greater sensitivity for tissue fluid with an inversion delay of 90 milliseconds. Two slice acquisitions per breath-hold were continued for 40-44 slices to image all of both lungs. The scanning time per breath-hold was 16 seconds, giving rise to a total acquisition time of 5.20-5.52 minutes, depending on total number of slices. A sensitivity-encoding factor of 2 was applied in the phase-encoding direction to increase acquisition speed.

A T1-weighted 3D multishot turbo field-echo sequence was used during breath-holds. The sequence was optimized with a turbo field-echo factor of 50, 24 turbo field-echo shots, and a radial turbo direction with the following acquisition parameters: TR/TE, 3.0/1.49; flip angle, 10°; number of excitations, 2; field of view, 400 mm; acquisition matrix size, 224 reconstructed to 512. Fat suppression was achieved with the spectral presaturation attenuated by inversion recovery method with an inversion delay of 90 milliseconds. Four consecutive slabs without a gap were obtained in the foot-to-head direction to image all of both lungs in a single breath-hold per slab. The slab thickness was 66 mm, and each slab was divided into 11 partitions to produce 11 images with a 6-mm section thickness. Imaging time per breath-hold was 13.5 seconds for one slab, giving rise to a total acquisition time of 54 seconds for four slabs covering the whole thorax.

Image Analysis
Two chest radiologists with 7 and 3 years of experience in chest CT interpretation and each with 2 years of experience in thoracic MRI interpretation, who reached the decisions on findings by consensus, performed all measurements retrospectively in a step-by-step manner [7]. First, the two chest radiologists assessed the CT images, which were used as reference standards. The reviewers evaluated primary lung cancer nodules for size, location, and morphologic features. The morphologic features estimated were presence or absence of a spiculated or lobulated margin, a satellite lesion, or a cavity within a nodule. The reviewers also assessed the presence of pulmonary nodules in lobes not containing primary tumors. If nodules were present, the radiologists recorded size, number, location, and presence or absence of calcification. The sizes of the pulmonary nodules were classified into three groups: 3-5 mm, 5-10 mm, and more than 10 mm in longest diameter.

Second, the two chest radiologists evaluated MR images obtained with T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE sequences using the same procedure as for the CT images. To avoid recall bias, the assessments of CT scans and MR images were scheduled more than 2 months apart. Third, corresponding CT and MRI data sets were reviewed simultaneously by the two radiologists for side-by-side comparison of primary lung cancer nodules in terms of size and morphologic characteristics. This assessment was followed by similar comparisons of the visibility, number, and size of nodules in lobes not containing primary tumors. Six small nodules in lobes not containing primary tumors were diagnosed histopathologically after wedge lung resection. The other small nodules in lobes not containing primary tumors were observed by follow-up with serial CT studies.

Statistical Analysis
The Friedman test was used to analyze statistical differences between longest measured diameters of primary lung cancer nodules on MDCT images and on T1-weighted 3D TSE and T2-weighted triple inversion black blood TSE 3-T MR images. Differences between the two 3-T MRI sequences in terms of diagnostic efficacy for morphologic characterization of primary lung cancer nodules and for detection of the presence of pulmonary nodules in lobes not containing primary tumors were tested for significance with the McNemar test and Bonferroni correction for multiple comparisons [14]. Significance was accepted at p < 0.05 for all tests.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Morphologic Characteristics of Primary Nodules
Of 127 patients included in the study, 15 had accompanying obstructive pneumonia or atelectasis, which precluded evaluation of the morphologic characteristics of primary lung cancer nodules. Therefore, a total of 112 patients were included. The morphologic characteristics of primary lung cancer nodules on CT scans and MR images obtained with T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE sequences are summarized in Table 1. Mean sizes of primary lung nodules differed significantly between CT and the two MRI sequences (p < 0.001, Friedman test). Post hoc analysis with ranks of least significant difference showed primary nodule diameter was significantly smaller on triple inversion black blood T2-weighted TSE images (38.1 ± 15.9 [SD] mm) than on CT scans (38.7 ± 16.2 mm) or 3D turbo field-echo MR images (38.4 ± 16.2 mm). No significant difference in primary nodule size was found between CT and 3D turbo field-echo MRI.


View this table:
[in this window]
[in a new window]

 
TABLE 1: Comparison of Morphologic Characteristics of 112 Primary Cancers Between Two MRI Sequences with CT Findings as Reference Standard

 

The morphologic characteristics of primary lung cancer nodules found on CT scans were as follows: spiculated and lobulated margins in 97% (109 of 112), accompanying satellite lesions in 13% (15 of 112), and a cavity within the primary lung cancer nodule in 17% (19 of 112) of the patients. These morphologic features were depicted on T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE images with the following accuracy rates: spiculated and lobulated margins, 97% (109 of 112) and 97% (109 of 112); satellite lesions, 93% (104 of 112) and 96% (107 of 112); and a cavity within the primary cancer nodule, 95% (106/112) and 96% (108/112). No significant differences were found between the two MRI sequences in depiction of the morphologic characteristics of primary lung cancer nodules.

Detection Rate of Pulmonary Nodules in Lobes Not Containing Primary Tumors
Three hundred twenty-three reference standard pulmonary nodules in lobes not containing primary tumors were found with CT in 89 (70%) of the 127 NSCLC patients. Of 323 nodules, 137 (42%) contained calcification, but the other 186 nodules did not. The overall detection rates for small nodules in lobes not containing primary tumors were 57% (184 of 323) on T1-weighted 3D turbo field-echo images and 56% (180 of 323) on T2-weighted triple inversion black blood TSE MR images (p = 0.64). Twenty-three (11%) of 207 small nodules detected on T1-weighted 3D turbo field-echo and 32 (15%) of 212 nodules detected on T2-weighted triple inversion black blood TSE images were false-positive findings. The positive predictive values for these nodules are shown in Table 2.


View this table:
[in this window]
[in a new window]

 
TABLE 2: 3-T MRI Detection Rate of Pulmonary Nodules in Lobes Not Containing Primary Tumors

 

The rate of detection of noncalcified nodules on T1-weighted turbo field-echo images was 53% (99 of 186); the rate for calcified nodules was 62% (85 of 137). The rate of detection of noncalcified nodules on T2-weighted triple inversion black blood TSE MR images was 57% (106 of 186); the rate for calcified nodules was 54% (74 of 137) (Table 2) (Fig. 1A, 1B, 1C).


Figure 1
View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A —68-year-old man with pleomorphic carcinoma in lower lobe of right lung and calcified small nodules in lobe not containing primary tumor. Transverse enhanced CT scan (5.0-mm thickness) at level of great vessels shows diffusely calcified (arrows) and noncalcified (arrowhead) nodules in right upper lobe, which proved to be benign granuloma on serial CT scans.

 

Figure 2
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B —68-year-old man with pleomorphic carcinoma in lower lobe of right lung and calcified small nodules in lobe not containing primary tumor. Transverse T1-weighted 3D turbo field-echo image at same level as A clearly shows diffusely calcified (arrows) and noncalcified (arrowhead) nodules with slightly higher signal intensity than chest wall muscle.

 

Figure 3
View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C —68-year-old man with pleomorphic carcinoma in lower lobe of right lung and calcified small nodules in lobe not containing primary tumor. T2-weighted triple inversion black blood turbo spin-echo image shows diffusely calcified nodules (arrows) are not clearly delineated; one calcified nodule is not identifiable. Noncalcified nodule (arrowhead) has higher signal intensity than chest wall muscle.

 
The rates of detection of small nodules in lobes not containing primary tumors classified according to the diameter of the nodules are summarized in Table 3. These rates increased as lesion size increased on MR images for both sequences, regardless of calcification. Specifically, these detection rates were 92% (48 of 52) on both on T1-weighted turbo field-echo and T2-weighted triple inversion black blood TSE images for noncalcified nodules larger than 5-10 mm in diameter.


View this table:
[in this window]
[in a new window]

 
TABLE 3: Comparison of Detection Rates According to the Diameter of Nodules in Lobes Not Containing Primary Tumor

 

In contrast, three biopsy-proven small metastatic nodules in lobes not containing primary tumors manifested higher signal intensity and greater diameter on T2-weighted triple inversion black blood TSE images than on T1-weighted 3D turbo field-echo images (Fig. 2A, 2B, 2C). Three biopsy-proven small benign pulmonary nodules (anthracofibrotic nodules) had lower signal intensity and smaller diameter on T2-weighted triple inversion black blood TSE images (Fig. 3A, 3B, 3C). For nodules larger than 10 mm in diameter, two calcified nodules were missed on T2-weighted triple inversion black blood TSE images, and a nodule of ground-glass opacity was missed on T1-weighted turbo field-echo images. Overall, detection rates according to nodule diameter were similar for T1-weighted turbo field-echo and T2-weighted triple inversion black blood TSE MRI (Table 3).


Figure 4
View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A —46-year-old man with adenocarcinoma in upper lobe of right lung and biopsy-proven metastatic nodule in lower lobe of right lung. Transverse lung-window CT scan at level of right upper lobar bronchus shows 5-mm nodule (arrow) in superior segment of right lower lobe. Nodule was pathologically proven metastatic adenocarcinoma. Bottom portion of primary lung adenocarcinoma (arrowheads) is evident in right upper lobe.

 

Figure 5
View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B —46-year-old man with adenocarcinoma in upper lobe of right lung and biopsy-proven metastatic nodule in lower lobe of right lung. T1-weighted 3D turbo field-echo (B) and T2-weighted triple inversion black blood turbo spin-echo (C) images show 5-mm nodule (straight arrow) in superior segment of right lower lobe. Nodule in C appears to have higher signal intensity than nodule in B. Primary adenocarcinoma (arrowheads) is present in right upper lobe. New triangular lesion (curved arrow) posterior to primary malignant nodule is result of hemorrhage caused by percutaneous needle aspiration biopsy.

 

Figure 6
View larger version (115K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C —46-year-old man with adenocarcinoma in upper lobe of right lung and biopsy-proven metastatic nodule in lower lobe of right lung. T1-weighted 3D turbo field-echo (B) and T2-weighted triple inversion black blood turbo spin-echo (C) images show 5-mm nodule (straight arrow) in superior segment of right lower lobe. Nodule in C appears to have higher signal intensity than nodule in B. Primary adenocarcinoma (arrowheads) is present in right upper lobe. New triangular lesion (curved arrow) posterior to primary malignant nodule is result of hemorrhage caused by percutaneous needle aspiration biopsy.

 

Figure 7
View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A —58-year-old man with squamous cell carcinoma in right upper lobe and biopsy-proven anthracofibrotic nodule in lobe not containing primary tumor. Transverse lung-window CT scan at level of basal segmental bronchus shows 9-mm subpleural nodule (arrow) in right middle lobe. Nodule was pathologically proven anthracofibrotic nodule.

 

Figure 8
View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B —58-year-old man with squamous cell carcinoma in right upper lobe and biopsy-proven anthracofibrotic nodule in lobe not containing primary tumor. T1-weighted 3D turbo field-echo (B) and T2-weighted triple inversion black blood turbo spin-echo (C) images show 9-mm nodule (arrow) in right middle lobe. Nodule is subtle in C and not easily visualized.

 

Figure 9
View larger version (88K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C —58-year-old man with squamous cell carcinoma in right upper lobe and biopsy-proven anthracofibrotic nodule in lobe not containing primary tumor. T1-weighted 3D turbo field-echo (B) and T2-weighted triple inversion black blood turbo spin-echo (C) images show 9-mm nodule (arrow) in right middle lobe. Nodule is subtle in C and not easily visualized.

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Although MRI has not been widely used as a primary tool for the evaluation of pulmonary nodules and parenchymal disease, technical improvements such as high field strength and refined sequences for lung imaging make it possible to evaluate pulmonary lesions with good anatomic resolution and high lesion contrast without ionizing radiation [8, 9, 11, 13, 15]. MRI is expected to be useful for nodal staging of NSCLC because it has acceptable diagnostic efficacy in the detection of nodal metastasis [4]. However, the efficacy MRI in the evaluation of pulmonary nodules has not been fully verified, and to the best of our knowledge, the efficacy of 3-T MRI has not been reported. The rate of detection of pulmonary nodules on MR images obtained with the HASTE sequence on a 1.5-T system was evaluated in one study [7]. The investigators reported a reasonable 85% overall rate of detection of small (mostly < 10 mm in diameter) pulmonary nodules. The detection rates according to pulmonary nodule size were as follows: 73% (281 of 383 nodules) for nodules smaller than 3 mm in diameter, 84% (253 of 300) for 3- to 5-mm nodules, 96% (222 of 232) for nodules measuring 5-10 mm, and 100% (187 of 187) for nodules larger than 10 mm. In another study [16] of the diagnosis of pulmonary metastasis with T2-weighted TSE sequences and a 1.5-T MRI system, the overall rate of detection of pulmonary metastasis was 84% (286 of 340 lesions), which comprised detection rates of 36% (17 of 47) for nodules smaller than 5 mm in diameter, 83% (88 of 106) for 5- to 10-mm nodules, 92% (69 of 75) for 10- to 15-mm nodules, and 100% (112 of 112) for 15- to 20-mm nodules. However, because T2-weighted TSE images have higher spatial resolution than T2-weighted HASTE images in imaging lung parenchyma [15] (although because of fast imaging, T2-weighted HASTE images are affected less by motion artifact than are T2-weighted TSE images), 73% or greater detectability of nodules less than 5 mm in diameter on HASTE images appears some-what questionable [7]. We evaluated the efficacy of 3-T MRI for detecting pulmonary nodules in a selected patient population—that is, patients with NSCLC who underwent MRI for evaluation of the diagnostic efficacy of the technique in determination of T and N stages. On both T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE images, primary malignant cancer was well visualized in terms of margin characteristics, presence of satellite nodules, and cavitation. The overall rate of detection of noncalcified small pulmonary nodules in lobes not containing primary tumors was 57% (106 of 186 nodules), with different detection rates for differently sized nodules: 40% for nodules 3-5 mm in diameter, 92% for nodules measuring 5-10 mm, and 100% for nodules larger than 10 mm on T2-weighted triple inversion black blood TSE MRI. However, the overall detection rate of 56% is lower than the 84% found in a previous study [16] of T2-weighted TSE sequences. This difference is probably due to the larger proportion of small (< 10 mm) pulmonary nodules, especially the larger proportion of nodules smaller than 5 mm, in our study.

In clinical practice, because they have little likelihood of being malignant, pulmonary nodules smaller than 5 mm in diameter found incidentally or identified in patients with lung cancer or with extrathoracic malignant tumors are not of great concern. Kim et al. [17] reported that pulmonary nodules smaller than 10 mm in diameter in lobes not containing primary tumors in patients with surgically resectable lung cancer have a low risk of metastasis (4%, six of 138 nodules). Therefore, it appears that clinically significant small (5-10 mm in diameter) pulmonary nodules are likely to be well depicted on T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE 3-T MR images.

In our study population, a large number of pulmonary nodules in lobes not containing primary tumors were calcified (42%, 137 of 323 nodules). Heavily calcified lesions have been classically characterized as having low signal intensity on both T1- and T2-weighted MRI, because calcium salts do not contain mobile protons and thus have no signal intensity on MR proton images [18, 19]. However, calcification per se shortens T2-weighted but not T1-weighted relaxation time. Thus, calcified small nodules may appear as unidentifiable lesions with highly exaggerated signal void effects under high-field-strength conditions. Moreover, calcified nodules can be visualized as lesions of variable signal intensity, even as high-signal-intensity lesions, on T1-weighted images. This factor depends on the particle size and precise composition of calcium salt aggregates [19, 20]. Our results for calcified nodules in lobes not containing primary tumors corroborate the aforementioned theories. On T2-weighted triple inversion black blood TSE images, the rate of detection of noncalcified pulmonary nodules in lobes not containing primary tumors was increased compared with the rate for calcified nodules. However, on T1-weighted 3D turbo field-echo images, the rate of detection of noncalcified nodules was decreased compared with the rate for calcified nodules (Table 2).

Other results of our study concern the efficacy of the T2-weighted triple inversion black blood TSE sequence in detection of metastatic pulmonary nodules. All three biopsy-proven metastatic pulmonary nodules in lobes not containing primary tumors had higher signal intensity and appeared larger in diameter on T2-weighted triple inversion black blood TSE images than on T1-weighted 3D turbo field-echo images. On the other hand, an anthracofibrotic nodule had lower signal intensity and appeared smaller in diameter on T2-weighted triple inversion black blood TSE images. These findings corroborated the fact that the fibrotic components of lesions have low MRI signal intensity and that closely packed tumor cells produce isointensity to high signal intensity on T2-weighted images [16, 21]. Therefore, size comparison between T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE sequences may help characterize small pulmonary nodules in lobes not containing primary tumors. Another advantage of the T2-weighted triple inversion black blood TSE sequence in the detection of small pulmonary nodule stems from its suppression of blood signal intensity. This technique causes vascular structures to become invisible in the peripheral aspect of the lung and thus improves detection of small pulmonary nodules.

There were limitations to our study. First, we included a relatively small number of nodules, especially nodules larger than 5-10 mm in diameter. Second, when we determined the optimal sequence for fast T2-weighted images of the thorax, we did not prospectively compare HASTE and T2-weighted triple inversion black blood TSE sequences. As a result, we are unsure which sequence is better for depicting small lung nodules. We plan to rectify this limitation with a prospective comparative study of the efficacy of detection of lung and mediastinal lesions with fast T2-weighted image sequences—namely, HASTE, T2-weighted triple inversion black blood TSE, and T2-weighted turbo STIR sequences—on a 3-T MRI system. Third, we lacked true volumetric acquisitions for the MRI sequences for comparison with the volumetric nature of MDCT. Fourth, we reconstructed both mediastinal and lung window images using a bone algorithm. Mediastinal window images reconstructed with a bone algorithm may have rings of high signal intensity at the interface of soft tissue and air. Thus small nodules may have falsely appeared bright and calcified.

In conclusion, 3-T MRI with T1-weighted 3D turbo field-echo and T2-weighted triple inversion black blood TSE sequences well shows primary lung cancer lesions with good anatomic resolution and lesion contrast in NSCLC patients. These sequences allow detection of clinically significant pulmonary nodules—that is, noncalcified nodules larger than 5 mm in diameter in lobes not containing primary tumors. Moreover, under 3-T conditions, MR images obtained with the T2-weighted triple inversion black blood TSE sequence are expected to more accurately depict small metastatic nodules in lobes not containing primary tumors than are images obtained with the T1-weighted 3D turbo field-echo sequence.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. [No authors listed]. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997;156 : 320-332[Free Full Text]
  2. Schaefer-Prokop C, Prokop M. New imaging techniques in the treatment guidelines for lung cancer. Eur Respir J2002; 35[suppl]:71S -83S
  3. Kauczor HU, Kreitner KF. Contrast-enhanced MRI of the lung. Eur J Radiol 2000;34 : 196-207[CrossRef][Medline]
  4. Ohno Y, Hatabu H, Takenaka D, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 2004;231 : 872-879[Abstract/Free Full Text]
  5. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging—perfusion differences in malignant and benign lesions. Radiology2004; 232:544 -553[Abstract/Free Full Text]
  6. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management—initial experience. Radiology2002; 224:503 -511[Abstract/Free Full Text]
  7. Schroeder T, Ruehm SG, Debatin JF, Ladd ME, Barkhausen J, Goehde SC. Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. AJR 2005;185 : 979-984[Abstract/Free Full Text]
  8. Gibbs GF, Huston J 3rd, Bernstein MA, Riederer SJ, Brown RD Jr. Improved image quality of intracranial aneurysms: 3.0-T versus 1.5-T time-of-flight MR angiography. Am J Neuroradiol2004; 25:84 -87[Abstract/Free Full Text]
  9. Dougherty L, Connick TJ, Mizsei G. Cardiac imaging at 4 Tesla. Magn Reson Med 2001;45 : 176-178[CrossRef][Medline]
  10. Tanenbaum LN. Clinical 3T MR imaging: mastering the challenges. Magn Reson Imaging Clin N Am 2006;14 : 1-15[CrossRef][Medline]
  11. Yamashita Y, Yokoyama T, Tomiguchi S, Takahashi M, Ando M. MR imaging of focal lung lesions: elimination of flow and motion artifact by breath-hold ECG-gated and black-blood techniques on T2-weighted turbo SE and STIR sequences. J Magn Reson Imaging1999; 9:691 -698[CrossRef][Medline]
  12. Takenaka D, Ohno Y, Hatabu H, et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 2002; 44:216 -224[CrossRef][Medline]
  13. Hatabu H, Gaa J, Tadamura E, et al. MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin-echo (HASTE) sequence. Eur J Radiol 1999;29 : 152-159[CrossRef][Medline]
  14. Bennett BM. On comparisons of sensitivity, specificity and predictive value of a number of diagnostic procedures. Biometrics 1972;28 : 793-800[CrossRef][Medline]
  15. Both M, Schultze J, Reuter M, et al. Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma. Eur J Radiol 2005; 53:478 -488[CrossRef][Medline]
  16. Kersjes W, Mayer E, Buchenroth M, Schunk K, Fouda N, Cagil H. Diagnosis of pulmonary metastases with turbo-SE MR imaging. Eur Radiol 1997; 7:1190 -1194[CrossRef][Medline]
  17. Kim YH, Lee KS, Primack SL, et al. Small pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J Thorac Imaging 2002;17 : 40-46[CrossRef][Medline]
  18. Greenberg JS, Javitt MC. MRI of an atypical bright MR signal of a calcified pulmonary nodule. J Comput Assist Tomogr1994; 18:834 -836[Medline]
  19. Gamsu G, de Geer G, Cann C, Muller N, Brito A. A preliminary study of MRI quantification of simulated calcified pulmonary nodules. Invest Radiol 1987;22 : 853-858[CrossRef][Medline]
  20. Tenner MS, Spiller M, Koenig SH, et al. Calcification can shorten T2, but not T1, at magnetic resonance imaging fields: results of a relaxometry study of calcified human meningiomas. Invest Radiol1995; 30:345 -353[CrossRef][Medline]
  21. Awaya H, Matsumoto T, Honjo K, Miura G, Emoto T, Matsunaga N. A preliminary study of discrimination among the components of small pulmonary nodules by MR imaging: correlation between MR images and histologic appearance. Radiat Med 2000;18 : 29-38[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
C. A Yi, K. M. Shin, K. S. Lee, B.-T. Kim, H. Kim, O J. Kwon, J. Y. Choi, and M. J. Chung
Non-Small Cell Lung Cancer Staging: Efficacy Comparison of Integrated PET/CT versus 3.0-T Whole-Body MR Imaging
Radiology, August 1, 2008; 248(2): 632 - 642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. A Yi, K. S. Lee, J. Han, M. P. Chung, M. J. Chung, and K. M. Shin
3-T MRI for Differentiating Inflammation- and Fibrosis-Predominant Lesions of Usual and Nonspecific Interstitial Pneumonia: Comparison Study with Pathologic Correlation
Am. J. Roentgenol., April 1, 2008; 190(4): 878 - 885.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yi, C. A
Right arrow Articles by Chung, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yi, C. A
Right arrow Articles by Chung, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS